Advanced Therapies Journal

Advanced Therapies Journal

Advanced Therapies Journal

Journal Archive

Advanced Therapies Journal was first published in 2018 as pharmacogenomics and Omics technologies  Journal and in 2023 reviewed for optimization and reformed to advanced therapies journal. Now ATJ is a premium home for the publication of interdisciplinary research on the next-generation of therapeutics and advanced therapies. The articles selected for the Editors' Choice are representative of the key topics that the journal publishes, including targeted drug delivery; drug discovery; cellular, genetic, and immunotherapies; personalized and precision medicines; theranostics; omics technologies, tissue engineering, pharmacology; toxicology, and highlight work done by researchers from across the globe.

Most Visited Articles
Advantages, Disadvantages and Risks of CRISPR/cas9 Technique for Gene Therapy
The Impact of Long-Term Exposure to Air Pollution on Cancer Risk
A Review of Medicinal Plant Extracts for the Treatment of Antibiotic-Resistant Wounds
Advancements and Potential Future Applications of Medication Delivery Systems Using Nanotechnology
CD40-CD40L Co-Stimulatory Pathway: A Promising Immune-Therapeutic Target in Systemic Lupus Erythematosus
Synthetic Biology in Genomics: Redefining Genetic Engineering and Its Applications in Personalized Medicine
Personalized Medicine Approach in the Treatment and Status of Autoimmune Diseases
Current Issue: Volume 8, Issue 28, Summer 2026, Pages 1-49 

Publication Information

Publisher
AmitisGen TECH Dev Group
Editor-in-Chief
Dr. Sina Salari
Director-in-Charge
Dr. Mohammad Ali Saremi
Executive Manager
Nayyere Moslehi
Frequency
Quarterly
Print ISSN
3115-7394
Online ISSN
3060-6152

Indexing and Abstracting

Google Scholar
Magiran
Civilica

Keywords Cloud

  • Personalized Medicine
  • precision medicine
  • Artificial intelligence
  • Machine Learning
  • Immunotherapy
  • Cancer therapy
  • Autoimmune disorders
  • Systemic lupus erythematosus
  • Genomic analysis
  • Biomarkers
  • breast cancer
  • Genomics
  • Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS)
  • Gene Therapy
  • Nanotechnology
  • CAR-T cell therapy toxicities
  • COVID-19
  • nanomedicine
  • Tumor Microenvironment
  • Precision oncology
  • Cytokine Release Syndrome (CRS)
  • cancer vaccine
  • Gut microbiota
  • Axonal regeneration
  • targeted therapy
  • Nanoparticles
  • probiotics
  • Nanocarriers
  • Cancer treatment
  • Pharmacogenomics
  • systemic lupus erythematosus (SLE)
  • Rheumatoid arthritis
  • Multiple Sclerosis
  • Synthetic biology
  • Multi-omics integration
  • cancer immunotherapy
  • Advanced Therapies
  • cancer
  • Monoclonal antibodies
  • Immune checkpoint inhibitors
  • Drug resistance
  • Aromatase Inhibitors (AIs)
  • , Adoptive Cell Therapy, Genetic Engineering
  • inflammatory bowel disease (IBD)
  • Combination therapy
  • immune modulation
  • Antibiotic resistance pediatric populations
  • phage display
  • individualized therapy
  • Vaccine development
  • Cancer Genomics
  • Precision tumor drug delivery
  • Nanobiotechnology
  • Cytokines
  • pharmacokinetics
  • Controlled drug delivery
  • tyrosine kinase inhibitors
  • Personalized therapies
  • Severity of disease
  • Biologics
  • Metastasis
  • Antimicrobial
  • solid tumors
  • Live materials
  • Genetic engineering
  • Lactococcus lactis
  • wound dressing
  • mRNA Vaccines
  • NSCLC
  • Targeted Delivery
  • Hydrogel
  • viral vector vaccines
  • Light-activated therapy
  • hydrogels
  • Cyclin-Dependent Kinase Inhibitors (CDK)
  • Traditional vaccines
  • Neural stem cells, CNS regeneration, Neuroplasticity, Immunomodulation
  • Predictive genetic biomarkers
  • Adoptive-cell therapy
  • Drug Development
  • Sickle cell disease
  • Biomaterials
  • burn management
  • COVID-19 meta-analysis
  • Pharmacogenomics, Precision Medicine
  • Phenylalanine ammonia-lyase
  • Health behavior
  • Age-Related Diseases
  • PD-1
  • Precision nanomedicine
  • Autoimmune Diseases
  • Colorectal cancer, Probiotics
  • Neuroplasticity, Immunomodulation
  • Neurodegenerative Diseases
  • breast malignancies
  • Antiviral therapy
  • Air pollution
  • immune system
  • Smart targeted nanoparticles
  • CD40-CD40L pathway
  • geriatric healthcare
  • Precision Diagnostics
  • Oncolytic Viruses
  • colorectal cancer
  • lupus nephritis
  • Antifungal therapy
  • Tumor lysis
  • Neurofilament Light Chain
  • risk factors
  • RET fusion
  • Pharmacological therapy
  • Urinary exosomes
  • Particulate Matter
  • Personalized therapy
  • Antimicrobial stewardship
  • Bacteriophage
  • Cellular Functions
  • Next-Generation Sequencing (NGS)
  • Precision Neurology
  • reactive oxygen species
  • CD154/CD40
  • Cancer management
  • Natural Antimicrobials
  • KRAS signaling
  • RET alterations
  • Oral-Gut Axis, Periodontal Disease, Microbiome Dysbiosis, Probiotics
  • Personalized medicine. Neutrophil
  • Inflammation
  • PBSC Manifestation
  • Host Genetic Variations, Respiratory Viral Infections, Disease Severity
  • Lung cancer
  • Chemotherapy response
  • cell therapy
  • Molecular profiling
  • Nanodrug Delivery
  • Chimeric antigen receptor
  • Chronic wounds
  • Solid Tumor
  • metabolomic signatures, Targeted therapy, Omics technologies
  • Niosomes
  • Antibiotic Resistance
  • Biomarker-guided
  • Psoriasis
  • age
  • Vaccinia virus
  • Diabetic foot ulcers
  • Regenerative medicine
  • DNA vaccine
  • therapy
  • infection prevention
  • Selective Estrogen Receptors Modulator (SERM)
  • Photodynamic therapy
  • targeted cancer therapy
  • Genomic data
  • Diabetes Mellitus
  • live biotherapeutic products
  • Antimicrobial Resistance
  • tumor vaccine
  • Alzheimer’s disease
  • Genetics
  • Multidisciplinary pain management
  • Gut microbiome
  • Drug Delivery
  • targeted drug delivery
  • Phenylketonuria
  • Radiation therapy
  • smoking
  • Tissue engineering
  • psoriatic arthritis
  • personalized treatments
  • Elderly Care
  • Engineered Regulatory T cells, CAR-Tregs
  • Gut microbiome, Targeted therapy, Microbial metabolites
  • gout
  • Antibody-Drug Conjugates
  • cytokine
  • Prostate Cancer
  • Non-pharmacological therapy
  • CRISPR/Cas9
  • Personalized Healthcare
  • CTLA-4
  • PD-L1
  • Drug delivery system
  • Autoimmune Disease
  • bioactive scaffolds
  • Neural stem cells, CNS regeneration
  • Active targeting
  • TKI
  • Viral Vector
  • plasmid engineering
  • β-thalassemia
  • Brachytherapy
  • Synthetic vaccines
  • non-invasive
  • neuroinflammation
  • Chronic pain
  • Cancer progression
  • Autoimmune Diseases, Immune Tolerance
  • Comprehensive analysis
  • Antibiotic delivery